BeyondSpring Inc.

NASDAQ:BYSI

Biotechnology

Healthcare
$1.25 +1.58%

+$0.03 today

Market cap
$51.40M
Beta
0.42
P/E (TTM)
-8.7
EPS (TTM)
-$0.19
52W Low $1.18High $3.28

Volume 0.01M

Average 0.02M

BYSI Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

BeyondSpring Inc.NASDAQ: BYSI

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 41.12M shares rose 2.0% year over year, in line with the +2.1% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.8% from the prior quarter. Over 3 fiscal years it compounded at +1.1% a year.

Context

  • Weighted avg shares increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.0% toward the trailing-twelve-month pace of +2.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
41.12M+1.8% QoQ
Last fiscal yearDec 2025
40.41M+1.7% YoY
LTMMar 2026
40.54M+2.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.0%——
1 year+1.7%——
3-year CAGR+1.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
40.41M USD
Year-over-year change
+1.7%
4-year CAGR
+0.9%

Weighted Avg Shares vs competitors

How BYSI compares with its peers on the latest reported figures

  • BYSI's LTM Mar 2026 weighted avg shares of 40.54M shares is the 7th highest of the 9 companies compared; the peer median is 55.18M shares.
  • Its year-over-year change of +2.1% is the lowest of 9, against a peer median of +49.7%.
  • Over three fiscal years its annual growth of +1.1% compares with a peer median of +21.3%.
BYSI Competitors Peer median
Weighted Avg Shares for BYSI and competitors
Company Period LTM YoY 3-year CAGR
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026107.08M +1278.7%+372.5%
ATYRaTyr Pharma, Inc.LTM Mar 202695.83M +20.8%+48.5%
GUTSFractyl Health, Inc. Common StockLTM Mar 202666.33M +37.1%+16.8%
BMEABiomea Fusion, Inc.LTM Mar 202656.46M +55.6%+21.3%
ALXOALX Oncology Holdings Inc.LTM Mar 202653.9M +2.3%+9.7%
HYFTMindWalk Holdings Corp.LTM Jan 202641.36M +43.8%+19.2%
BYSIBeyondSpring Inc.LTM Mar 202640.54M +2.1%+1.1%
CAMPCAMP4 Therapeutics CorporationLTM Mar 202637.54M +102.0%—
DTILPrecision BioSciences, Inc.LTM Mar 202612.13M +61.6%+63.6%
Peer median (excluding BYSI) 55.18M+49.7%+21.3%

Competitors are the stored peer set for BYSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.35M1.35M000
Cost of Revenue00302K087K
Gross Profit1.35M1.35M(302K)0(87K)
Gross Margin100.0%100.0%———
Research & Development36.89M25.58M7.27M2.64M4.39M
Selling, General & Admin30.7M13.01M7.51M6.11M4.56M
Operating Expenses67.59M38.59M14.78M8.75M8.86M
Depreciation & Amortization61K1.14M302K285K87K
EBITDA(64.49M)(34.96M)(13.62M)(8.48M)(8.54M)
EBITDA Margin-4773.5%-2587.4%———
Operating Income(66.24M)(37.24M)(15.08M)(8.75M)(8.95M)
Operating Margin-4903.0%-2756.4%———
Interest Income98K195K421K59K78K
Interest Expense87K17K000
Other Income / Expenses1.6M1.12M1.16M(15K)320K
Income Before Tax(64.64M)(36.12M)(13.92M)(8.77M)(8.63M)
Pre-Tax Margin-4784.5%-2673.4%———
Income Tax Expense3.57M163K92K96K90K
Net Income(64.18M)(33.28M)(21.03M)(11.12M)(7.99M)
Net Margin-4750.5%-2463.3%———
EPS (Basic)(1.64)(0.85)(0.54)(0.28)(0.20)
EPS (Diluted)(1.64)(0.85)(0.54)(0.28)(0.20)
Weighted Avg Shares39.02M39.09M39M39.73M40.41M
Weighted Avg Shares (Diluted)39.02M39.09M39M39.73M40.41M

BeyondSpring Inc.

NASDAQ:BYSI

Intrinsic Alpha fair value

Locked

Current Price

$1.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.